A detailed history of Farallon Capital Management LLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Farallon Capital Management LLC holds 1,150,221 shares of AMLX stock, worth $4.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,150,221
Previous 1,150,221 -0.0%
Holding current value
$4.6 Million
Previous $2.19 Million 70.53%
% of portfolio
0.02%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$2.71 - $19.57 $3.12 Million - $22.5 Million
1,150,221 New
1,150,221 $3.27 Million

Others Institutions Holding AMLX

About Amylyx Pharmaceuticals, Inc.


  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $234M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track Farallon Capital Management LLC Portfolio

Follow Farallon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.